An ApoB test measures the number of cholesterol-carrying particles in your blood that can lodge in artery walls and start plaque. Because it counts particles instead of estimating the cholesterol they carry, an apolipoprotein B result often reveals heart risk that a standard LDL cholesterol number can miss. That is why cardiologists increasingly order it alongside a routine cholesterol panel. In this article you will learn what the test measures, how it compares with LDL-C, how to read your result, the targets doctors use, and when testing makes sense.
What an ApoB test measures
Apolipoprotein B (ApoB) is a protein that sits on the surface of every particle that can drive atherosclerosis: low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a). Each of these particles carries exactly one ApoB molecule, and the “good” HDL particles carry none. Because of that one-to-one relationship, measuring ApoB gives a direct count of the total number of plaque-forming particles circulating in your blood.
This is the key idea behind the test. A traditional cholesterol panel tells you how much cholesterol your particles are carrying. An ApoB test tells you how many particles there are. Two people can carry the same amount of LDL cholesterol in very different numbers of particles, and the person with more particles is generally at higher risk. To see how ApoB fits with the other fats measured in a routine draw, you can review a standard lipidenpanel.
ApoB vs LDL-C: why the difference matters
LDL cholesterol (LDL-C) has anchored heart-risk assessment for decades, and it remains useful. The problem is that LDL-C estimates a mass of cholesterol, not a particle count. When particles are smaller and denser, as often happens in diabetes, metabolic syndrome, or high triglycerides, the same LDL-C value can hide a much larger number of particles. Doctors call this mismatch discordance, and it is where an ApoB test earns its place.
| Meeteenheid | What it captures | Waarom dit belangrijk is |
|---|---|---|
| LDL-C | Estimated cholesterol carried by LDL particles | Familiar, widely available risk indicator |
| Non-HDL-C | Cholesterol in all atherogenic particles combined | More complete than LDL-C alone |
| ApoB | Aantal atherogene deeltjes | Most direct count of the plaque-forming particle burden |
ApoB is not the same as LDL, but a high ApoB usually means a high number of LDL particles. It also captures particles that LDL-C leaves out, such as lipoprotein(a); if that marker runs in your family, it is worth measuring your lipoproteïne(a) at least once. Some clinicians round out the picture with the mirror-image protein on HDL, apolipoproteïne A1, to gauge the balance between harmful and protective particles.
How to read your ApoB test result
ApoB is reported in milligrams per deciliter (mg/dL). Most adult results fall between 20 and 400 mg/dL, and laboratories publish reference ranges that differ slightly by sex. Your own result should always be read next to your age, sex, and overall risk, so treat the figures below as general guidance rather than a diagnosis.
| ApoB result (mg/dL) | Algemene interpretatie |
|---|---|
| Under 80 | Often used as an optimal goal, especially for people already treated for high cholesterol |
| 66–133 (men) / 60–117 (women) | Commonly cited reference range for adults |
| 90 of hoger | Considered elevated by many laboratories |
| 130 or higher | High, and linked to greater heart and blood-vessel risk |
A result above 130 mg/dL points to higher cardiovascular risk and usually prompts the same steps a doctor would advise for high LDL cholesterol. A number in the reference range is reassuring but does not cancel out other risk factors such as blood pressure, smoking, or family history.
ApoB targets by risk level
Targets are lower than reference ranges because the goal of treatment is to reduce risk, not simply to stay inside a laboratory’s normal band. Many cardiology guidelines suggest an ApoB below 80 mg/dL, and below 65 mg/dL for higher-risk adults aged 40 to 75 who take a statin. These goals track the lower LDL-C goals set for the same groups.
The 2026 ACC/AHA dyslipidemia guideline positions ApoB as a tool to refine risk rather than replace LDL-C. It recommends measuring ApoB to assess any remaining risk and guide treatment in people with cardiovascular-kidney-metabolic syndrome, type 2 diabetes, high triglycerides, or established heart disease who have already reached their LDL-C and non-HDL-C goals. In those groups, the guideline notes, ApoB may be a more accurate risk marker than LDL-C. If you want to see how these numbers relate, you can also review your cholesterolratio.
When should you get an ApoB test?
An ApoB test is most useful when a standard panel leaves uncertainty. Your provider may suggest it if you have:
- Diabetes, metabolic syndrome, or insulin resistance
- High triglycerides or a normal LDL-C that still seems at odds with your risk
- A family history of early heart attack or stroke
- Overweight, obesity, or chronic kidney disease
- An established cardiovascular condition that you are actively managing
You do not need to fast for an ApoB measurement on its own, although a 12-hour fast is usually requested when it is drawn together with a full lipid panel. In the United States, independent laboratories often offer the test for under $100. People who also carry a low protective fraction, such as laag HDL-cholesterol, tend to gain the most extra information from adding ApoB.
What can raise or lower ApoB
Several conditions shift ApoB up or down for reasons unrelated to long-term risk, which is one more argument for interpreting your result in context. Levels can read higher with high cholesterol, pregnancy, or nephrotic syndrome (a kidney disorder). They can read lower with severe infection such as sepsis, with liver disease, or while taking estrogen. Lifestyle also moves the number over time: eating pattern, physical activity, body weight, tobacco, and alcohol all influence how many atherogenic particles your liver produces.
Latest scientific advances on ApoB
Recent research has steadily strengthened the case for counting particles rather than cholesterol mass. Here is what the newest evidence adds, in plain terms.
A 2022 review in the Journal of the American Heart Association laid out the biology behind ApoB’s edge: because risk is driven by the number of particles trapped in the artery wall, and each particle carries one ApoB, the test measures the thing that actually causes plaque. What this means for you is that ApoB is not just another cholesterol number, but a more direct readout of the process behind heart disease.
A 2023 analysis in Pharmacological Research reached a practical conclusion: ApoB is a better stand-in for risk than LDL-C, especially in people with diabetes, several cardiometabolic risk factors, or high triglycerides with low LDL-C. The authors suggest measuring both LDL-C and ApoB to estimate overall risk and to check how well treatment is working. For a reader, that supports asking about ApoB when your usual cholesterol picture looks reassuring but your other risk factors do not.
A 2025 study followed more than 41,000 adults in the UK Biobank (a large group tracked over time) for a decade. When ApoB disagreed with the LDL particle count, ApoB was the better predictor of heart attacks and blocked arteries, and risk was already higher even when the two measures were only slightly out of step. In everyday language: even a small mismatch between what your cholesterol suggests and what your particle count shows can matter, which is exactly the gap ApoB is designed to close. These findings are still being confirmed across different populations, but they point consistently in the same direction.
ApoB is only one number in a wider workup. To see how it sits alongside lipoprotein(a), ApoA1, and particle ratios, read our companion guide to the geavanceerd lipidenpanel.
Glossarium
- ApoB (apolipoprotein B): the protein carried by every atherogenic particle; a marker of particle number.
- Apolipoprotein: a protein that gives a lipoprotein particle its structure and destination.
- LDL-C: low-density lipoprotein cholesterol, the traditional measure of “bad” cholesterol.
- Non-HDL-C: total cholesterol minus HDL, capturing all atherogenic particles together.
- Atherogenic: able to promote plaque formation in artery walls.
- Lipoprotein(a): an inherited, ApoB-containing particle that adds independent cardiovascular risk.
- Discordance: a mismatch between cholesterol mass (LDL-C) and particle number (ApoB).
- VLDL: very-low-density lipoprotein, a triglyceride-rich atherogenic particle.
Veelgestelde vragen
How much does an ApoB test cost? In the United States, independent laboratories commonly charge under $100, and many insurers cover it when a provider orders it for cardiovascular risk assessment. Prices vary by lab and region, so confirm before testing.
What is a normal ApoB level? Widely cited reference ranges are about 66 to 133 mg/dL for men and 60 to 117 mg/dL for women, with treatment goals set lower, often below 80 mg/dL. Ranges shift slightly by laboratory and by age, so read your result against your own risk profile.
Do I need to fast for an ApoB test? Not for ApoB alone. If it is drawn together with a full lipid panel, you will usually be asked to fast for about 12 hours, with water allowed.
Is ApoB the same as LDL? No. LDL cholesterol estimates the cholesterol inside LDL particles, while ApoB counts the particles themselves. A high ApoB does, however, signal a high number of LDL particles.
Who should consider an ApoB test? People with diabetes, metabolic syndrome, high triglycerides, a strong family history of heart disease, or a normal LDL-C that seems inconsistent with their risk often gain the most from it.
Can a high ApoB be lowered? Yes. The same measures that lower LDL cholesterol, such as a heart-healthy diet, regular activity, weight management, avoiding tobacco, and, when needed, cholesterol-lowering medication, also reduce ApoB. Any treatment plan should be set with your doctor.
Verder lezen
- Advanced lipid panel: the full atherogenic workup
- Standard lipid panel explained
- Apolipoprotein A1 and protective particles
- Lipoprotein(a) screening
- Hoog cholesterol: begrijpen, voorkomen, handelen
Bronnen
- Cleveland Clinic. Apo B Test. https://my.clevelandclinic.org/health/diagnostics/24992-apolipoprotein-b-test
- American College of Cardiology / American Heart Association. 2026 Guideline for the Management of Dyslipidemia (news release), 2026. https://newsroom.heart.org/news/accaha-issue-updated-guideline-for-managing-lipids-cholesterol
- Devaraj S, Semaan JR, Jialal I. Biochemistry, Apolipoprotein B. StatPearls, NIH National Library of Medicine, 2023. https://www.ncbi.nlm.nih.gov/books/NBK538139/
- Glavinovic T, et al. Physiological Bases for the Superiority of Apolipoprotein B Over LDL-C and Non-HDL-C as a Marker of Cardiovascular Risk. J Am Heart Assoc, 2022. https://consensus.app/papers/details/6741445f381856cd94646adfa7be738b/
- Galimberti F, et al. Apolipoprotein B compared with LDL cholesterol in atherosclerotic cardiovascular disease risk assessment. Pharmacological Research, 2023. https://consensus.app/papers/details/e165d86a53585f0b99bbf189389a1153/
- Epstein E, et al. Apolipoprotein B outperforms LDL particle number as a marker of cardiovascular risk in the UK Biobank. Eur J Prev Cardiol, 2025. https://consensus.app/papers/details/4b787ca8162d5dbe969b3f334d8ead3a/
Begrijp uw laboratoriumresultaten met AI DiagMe.
An ApoB result is easier to act on when you can see it next to your LDL-C, triglycerides, and other markers in plain language. AI DiagMe reads your uploaded lab report and explains what your apolipoprotein B, cholesterol, and particle numbers may mean for your heart, highlighting patterns to discuss with your doctor. It helps you understand your results; it does not diagnose disease or replace your physician.
Ontvang binnen enkele minuten een interpretatie van uw resultaten.
